SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
580>> No PR from the company << Remember, there was no company responsscaram(o)uche-1/23/2005
579Thanks for that. Rough translation from freetranslation.com: Before an objectituck-1/22/2005
578Patent zu Ovarial- und Brustkrebs Empfindlichkeitsgen nach öffentlicher Verscaram(o)uche-1/22/2005
577Öffentliche Einspruchsverhandlungen zu zwei Gentechnik-Patenten („Brustkrebscaram(o)uche-1/22/2005
576Wow. That was a cool day. Can't believe that the massive two days of selliscaram(o)uche-1/21/2005
575right here, pushing up against a 52 week high and after a good run... someonescaram(o)uche-1/20/2005
574Best news to date... Fulcrum is on the ask, most likely shorting. We got true scaram(o)uche-1/20/2005
573United States Patent 6,844,189 Tavtigian , et al. January 18, 2005 ----scaram(o)uche-1/20/2005
572No gtxi thread on Si, somewhat surprising. So I'll just put this here for thkeokalani'nui-1/16/2005
571BMC Geriatr. 2005 Jan 12;5(1):2 [Epub ahead of print] Nonsteroidal anti-inflamscaram(o)uche-1/15/2005
570pointer from yahoo thread, a little color here and there..... sltrib.com Articscaram(o)uche-1/13/2005
569J Biol Chem. 2005 Jan 11; [Epub ahead of print] The role of LIP5 and CHMP5 in scaram(o)uche-1/13/2005
568I was thinking in terms of efficacy, as we don't have much data on that yet.tuck-1/12/2005
567When I think "powering", I think about long-term dosing to at least 60scaram(o)uche-1/12/2005
566I'll bet the boys at Avalon are a bit surprised. Everybody here happy with tuck-1/12/2005
565Ditto thanks, Ricktom pope-1/12/2005
564Ditto (but sold only 25% :-)).nigel bates-1/12/2005
563Ditto congrats and thanks. I bought some last year and sold 1/2 a few days agokeokalani'nui-1/12/2005
562Myriad Genetics Starts Alzheimer's Trial Wednesday January 12, 3:52 pm ET scaram(o)uche-1/12/2005
561Yeah, I would say that Rick is on a bit of a roll here (MYGN, ACAD, others?)...FiloF-1/12/2005
560MYGN Wow! Gratz 'n' Thanx Rick! Now if only you can improve your insigDoc Bones-1/12/2005
559solid presentation, IMO.... sounds like PM revenues continue to grow at a goodscaram(o)uche-1/12/2005
558Hobden is giving the presentation. Cool.scaram(o)uche-1/12/2005
557United States Patent 6,841,352 Ostanin January 11, 2005 -----------------scaram(o)uche-1/12/2005
556Myriad Genetics Initiates Phase 3 Clinical Trial of Flurizan(TM) in Alzheimerscaram(o)uche-1/12/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News